Christian Hassig serves as Chief Scientific Officer at Boundless Bio, Inc., where they oversee executive responsibilities. Since joining the company, Christian Hassig has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 23, 2026 involved receiving (via award) 230,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 23, 2026 | BOLD | $0 | Award | 230,000 | $N/A | Discretionary |
Christian Hassig currently holds 230,000 shares of Boundless Bio, Inc. (BOLD), valued at approximately $0. This represents their equity stake as Chief Scientific Officer.
Based on SEC Form 4 filings, Christian Hassig has been a net neutral trader of BOLD stock. They have purchased $0 and sold $0 worth of shares.
Christian Hassig's most recent insider trade was on Jan 23, 2026, when they sold 230,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted